Molecular determinants of KRAS G12C inhibitor efficacy in advanced NSCLC VJOncology 1:59 1 year ago 112 Далее Скачать
Key lung cancer updates: KRAS(G12C) inhibitors and ADCs VJOncology 2:38 3 years ago 283 Далее Скачать
KRAS G12C Inhibitors: Acquired Resistance and Combo Strategies Targeted Oncology 5:23 4 years ago 621 Далее Скачать
Sotorasib shows as a tolerable treatment option for patients with KRASG12C-mutated advanced NSCLC ecancer 4:19 1 year ago 164 Далее Скачать
KRYSTAL-1 and CodeBreak 100: targeting KRAS G12C in lung cancer VJOncology 1:26 3 years ago 180 Далее Скачать
Phase II CodeBreak 100 trial of sotorasib in advanced NSCLC VJOncology 3:01 3 years ago 270 Далее Скачать
CodeBreaK 200: sotorasib versus docetaxel in pretreated KRAS G12C-mutant NSCLC VJOncology 2:42 2 years ago 285 Далее Скачать
The role of immunotherapy with KRAS inhibitors in KRAS-driven NSCLC VJOncology 0:47 2 years ago 350 Далее Скачать
Mechanisms of acquired resistance to KRAS G12C inhibition in cancer ecancer 4:29 3 years ago 401 Далее Скачать
Safety of sotorasib and panitumumab in advanced KRAS p.G12C-mutated colorectal cancer ecancer 7:19 3 years ago 421 Далее Скачать
